These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 9809194)
21. [Arguments for the existence of an endogenous inhibitor of renal Na-K ATPase with steroid structure and natriuretic action]. Krzesinski JM; Christiaens L; Palem-Vliers M; Fenghe D; Pequeux-Bar ML; Lomba-Pignon MR; Genard P; Rorive G Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1229-31. PubMed ID: 2175582 [TBL] [Abstract][Full Text] [Related]
22. Dependency of renal potassium excretion on Na,K-ATPase transport rate. Sejersted OM; Monclair T; Mathisen O; Hartmann A; Kiil F Acta Physiol Scand; 1985 Jan; 123(1):9-19. PubMed ID: 2982247 [TBL] [Abstract][Full Text] [Related]
23. Prolactin, a natriuretic hormone, interacting with the renal dopamine system. Ibarra F; Crambert S; Eklöf AC; Lundquist A; Hansell P; Holtbäck U Kidney Int; 2005 Oct; 68(4):1700-7. PubMed ID: 16164646 [TBL] [Abstract][Full Text] [Related]
24. The role of endogenous inhibition of Na-K-ATPase in human hypertension--sodium pump activity as a determinant of peripheral vascular resistance. Kramer HJ; Glänzer K; Sorger M Clin Exp Hypertens A; 1985; 7(5-6):769-82. PubMed ID: 2990771 [TBL] [Abstract][Full Text] [Related]
25. Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2. Gunning ME; Brady HR; Otuechere G; Brenner BM; Zeidel ML J Clin Invest; 1992 May; 89(5):1411-7. PubMed ID: 1533229 [TBL] [Abstract][Full Text] [Related]
27. The possible role of endogenous digitalis-like substance in the regulation of circadian changes in urinary electrolyte excretion in man. Morise T; Okamoto S; Ikeda M; Takeda R Endocrinol Jpn; 1989 Dec; 36(6):845-50. PubMed ID: 2561276 [TBL] [Abstract][Full Text] [Related]
28. Evidence That Binding of Cyclic GMP to the Extracellular Domain of NKA (Sodium-Potassium ATPase) Mediates Natriuresis. Kemp BA; Howell NL; Gildea JJ; Hinkle JD; Shabanowitz J; Hunt DF; Conaway MR; Keller SR; Carey RM Circ Res; 2023 Apr; 132(9):1127-1140. PubMed ID: 36919600 [TBL] [Abstract][Full Text] [Related]
29. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade. Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261 [TBL] [Abstract][Full Text] [Related]
30. Two brain inhibitors inhibit renal Na,K-ATPases without recognizing the species-dependent variation of their ouabain-sensitivity. Anner BM Clin Exp Hypertens; 1998; 20(5-6):489-97. PubMed ID: 9682905 [TBL] [Abstract][Full Text] [Related]
31. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension. Hasegawa T; Masugi F; Ogihara T; Kumahara Y J Clin Hypertens; 1987 Dec; 3(4):419-29. PubMed ID: 2839625 [TBL] [Abstract][Full Text] [Related]
32. Further biochemical characterization of an Na+ pump inhibitor purified from human urine. Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785 [TBL] [Abstract][Full Text] [Related]
33. Role of atrial natriuretic peptide in long-term volume homeostasis. Lohmeier TE; Mizelle HL; Reinhart GA Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):55-61. PubMed ID: 7768035 [TBL] [Abstract][Full Text] [Related]
34. A plasma inhibitor of sodium and potassium activated adenosine triphosphatase in patients with essential hypertension. Toriyabe S; Miura Y; Kimura S; Meguro Y; Sugawara T; Noshiro T; Takahashi M; Ohashi H; Sano N; Watanabe H Tohoku J Exp Med; 1988 Jun; 155(2):129-37. PubMed ID: 2850642 [TBL] [Abstract][Full Text] [Related]